Page 4 - Reverse Transcriptase News Today

In a new study, researchers conducted a retrospective analysis of the SAR-CoV-2 reverse transcriptase - quantitative polymerase chain reaction test measurements.

A new study shows both the Omicron and Delta variants were able to infect patients with healthy immune function.

In a recent study posted to the medRxiv*preprint server, a team of researchers from Israel developed and validated novel reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR) assays. The new assays enable the rapid and high throughput identification and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 variants.

In a new study, researchers determined the transcriptional signatures associated with the severity of COVID-19.

As The Epoch Times and other media outlets reported yesterday, a shocking new study conducted at Lund University in Sweden has confirmed that mRNA nanoparticles from Pfizer's covid-19 [...]

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

Researchers conduct genomic wastewater surveillance of SARS-CoV-2 following the emergence of the Alpha and Delta variants in the United Kingdom.

In a recent study posted to the medRxiv* pre-print server, researchers simulated several wearable sensor deployment scenarios to demonstrate the potential of digital contact tracing technology in mitigating the coronavirus disease 2019 (COVID-19) pandemic.

New LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG increases flexibility while retaining performance

Researchers used an ABM to simulate SARS-CoV-2 spread in the United States and India.